Junlebao Dairy Group Co., Ltd.
- Country
- 🇨🇳China
- Ownership
- Holding
- Established
- 2000-04-21
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.jlbry.com
Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
The Trial of a New Infant Formula in Healthy Term Chinese Infants
- Conditions
- Healthy Infants
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Junlebao Dairy Group Co., Ltd.
- Target Recruit Count
- 326
- Registration Number
- NCT06053112
- Locations
- 🇨🇳
Affiliated Hospital of Jining Medical College, Jining, China
🇨🇳Shanghai Public Health Clinical Center affiliated to Fudan University, Shanghai, China
🇨🇳Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Research on the Characteristics and Application of Lactobacillus Rhamnosus X253 as Oral Probiotics
- Conditions
- Dental Caries
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2021-11-17
- Lead Sponsor
- Junlebao Dairy Group Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05123651
- Locations
- 🇨🇳
Shijiazhuang JunlebaoDairy Co.Ltd., Shijiazhuang, Hebei, China
A Study on Efficacy of Feeding N1115 Probiotic Supplement to Young Children
- Conditions
- Intestinal Growth of Young Children
- First Posted Date
- 2018-01-31
- Last Posted Date
- 2018-07-24
- Lead Sponsor
- Junlebao Dairy Group Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT03416595
- Locations
- 🇮🇪
Atlantia Clinical Food Trials, Cork, Blackrock, Ireland
News
Probiotic Supplementation Alters Gut Microbiota in Peritoneal Dialysis Patients
A randomized, double-blind, placebo-controlled study investigated the impact of probiotic supplementation on gut microbiota in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).